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Purpose: Gliclazide has been found to form inclusion complexes with β- cyclodextrin (β-CD) in 
solution and in solid state. The present study was undertaken to determine a suitable method for 
scaling up gliclazide-β-CD inclusion complex formation and to evaluate the effect of some parameters 
on the efficiency of complexation. 
Method: The solid inclusion complexes of gliclazide and β-cyclodextrin were prepared at a molar ratio 
of 1:1 and 1:2 by mixing, kneading, and coprecipitation methods both on small and large scales. The 
effect of parameters such as kneading time and temperature on complexation was also studied. 
Characterization was performed using infrared spectroscopy, X-ray diffractometry, and dissolution 
studies. In vitro release studies were carried out in phosphate buffer (pH 6.8).  
Result: All the methods of preparation of complexes were found to be useful in increasing the 
solubility of gliclazide except mixing method where the rise in solubility was not significant. Both 
kneading and co-precipitation methods in 1:2 molar ratios were found to be equally effective in 
improving the solubility of gliclazide. The formation of inclusion complexes was evident in these 
formulations as shown by IR and XRD studies. But when carried out on a large scale, co-precipitation 
method was found to be more tedious and time-consuming than kneading method. Moreover percent 
recovery of complexes in the kneading method was found to be 98.76% as compared to 92.05% in 
case of co-precipitation method.   
Conclusion: Drug content studies, IR spectroscopic studies, X-Ray diffractometry studies and in vitro 
dissolution study data indicated that inclusion complexes prepared by kneading method in 1:2 molar 
ratios were suitable for improving the solubility of gliclazide. The same formulation was prepared at 
large scale and optimum formulation conditions were established. 
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INTRODUCTION 
Cyclodextrins (CDs) are cyclic 
oligosaccharides, containing a minimum of six 
D-(+)-glycopyranose units attached by α-1,4-
linkages produced by the action of the 
cyclodextrin-trans-glycosidase enzyme on a 
medium containing starch. It has a 
hydrophobic central cavity and a hydrophilic 
outer surface1. CDs have been found to be 
very useful in enhancing the solubility of poorly 
water-soluble drugs owing to the formation of 
inclusion complex of the drug in its 
hydrophobic cavity2-6. The most common 
natural CDs are α-cyclodextrin, β-cyclodextrin 
and γ-cyclodextrin, which are formed by six, 
seven, and eight glucose units, respectively. 
Apart from these naturally occurring CDs, 
various derivatives are also available7,8 which 
may produce better solubility when 
complexed9,10 but cost and toxicity factors 
poses limitation in their use. Amongst the 
various available CDs, β-cyclodextrins  (β-CD) 
are the cheapest and are nontoxic for oral 
use11. 
Gliclazide (Glz) is a second-generation 
sulphonylurea oral hypoglycemic agent used in 
the treatment of non-insulin dependent diabetes 
mellitus. It stimulates insulin secretion by 
pancreatic beta cells. In the long-term, it reduces 
hepatic gluconeogenesis, and increases insulin 
effects by acting at receptor or post-receptor 
sites. It also inhibits platelet aggregation and 
increases fibrinolysis12. But the problem with this 
potentially useful hypoglycemic agent is that it is 
practically insoluble in water. This limits its 
bioavailability and may be the reason for its 
delayed absorption13. 
 
Since CDs are relatively more water-soluble 
molecules and Glz can form inclusion complex 
with this, it can be used as a solubility enhancer 
for Glz14-16. Several methods have been 
proposed to obtain solid drug-CD complexes, 
both in liquid and in solid medium, but there is 
still no general rule or universal method, 
probably because each drug to be entrapped is 
a special case and optimal conditions depend on 
the characteristic of both the host and guest 
molecules. Selection of the most suitable 
preparation method for a given drug requires 
careful evaluation because apart from 
consideration of the performance of the obtained 
product, such as the dissolution profile, other 
factors such as simplicity, low cost, high yield, 
swiftness and ease of scale-up also play a major 
role in the choice of a method.  
The objective of the present study was to 
compare the physicochemical properties and 
dissolution profiles of the inclusion complexes 
of Glz-β-CD prepared by different methods in 
order to devise a suitable method that is 
easier, less costly, faster and produces high-




Both β- Cyclodextrin and Gliclazide were 
received from Zim Laboratories Ltd., Nagpur, 
India, as gift samples. Potassium dihydrogen 
phosphate (35.084 g) and disodium hydrogen 
phosphate (28.80 g) were dissolved in 1000 ml 
of water to produce phosphate buffer of pH 6.8. 
All the reagents and solvents were analytical 
grade, and double distilled water was used. 
 
METHODS 
Phase Solubility Studies 
Phase solubility studies were carried out 
according to the method reported by Higuchi 
and Connors17. Excess amounts of gliclazide 
were added to phosphate buffer solutions (pH-
6.8) containing β-cyclodextrin in different molar 
concentrations and stirred for four days at 
constant temperature. The filtered solutions 
were analyzed on a double beam UV 
spectrophotometer (SHIMADZU UV2401PC, 
Kyoto, Japan) at 226 nm, after diluting suitably 
with phosphate buffer, to define solubility 
characteristics. 
 
Physical mixing method 
Gliclazide and β-CD were blended in the mortar 
for 30 min in molar ratios of 1:1 and 1:2 (GPM1 
and GPM2) the total weight of the mixture was 
100g.   The physical mixtures were also   
prepared at large scale by blending gliclazide 
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with β-CD (in the same ratio) total weight of 
approx 20kg in a rapid mass granulator (GMI, 
Mumbai, INDIA) for 30mins. These powdered 
physical mixtures were then stored in the room 
at controlled temperature (25° ± 2.0°) and 
humidity conditions (Relative humidity 40-50%) 




Gliclazide and β-CD in the molar ratios of 1:1 
and 1:2 (GK1 and GK2) were wetted with 
appropriate quantity of water so as to obtain a 
paste. Both 1:1 and 1:2 molar ratios were then 
subjected to different trituration timings ranging 
from 15 min. to 1 hr. This was done to study the 
effect of trituration time over the effective 
complexation. After that it was dried at 50o C, 
for one day, crushed, sieved and stored at 
temperature of 25° ± 2.0° and relative humidity 
between 40-50%. For small scale mortar and 
pestle was used while for large scale rapid 
mass granulator was used. The kneading 
method was repeated at 75oC. 
 
Co-precipitation method  
Gliclazide (3.23 g) was dissolved in minimum 
quantity of acetone and was added drop wise 
to the solution of β-CD (11.35 g for GCP1 and 
22.7 g for GCP2) in minimum quantity of water 
previously maintained at 75oC while stirring. 
Stirring was maintained for 1 h at 75oC. Then 
gradually it was cooled to room temperature 
while stirring. The precipitates were then 
filtered, dried and stored at temperature of 25° 
± 2.0° and relative humidity between 40-50%. 
The experiment was carried out both at small 
and large scale in 1:1 and 1:2 molar ratios 
(GCP1 and GCP2). 
 
Drug Content Measurements 
After 3 days of storage, all the powders obtained 
were assayed spectrophotometrically 
(Shimadzu, UV2401PC spectrophotometer) at 
226 nm by dissolving in methanol to determine 
the percent yield of all the methods. 
 
IR Spectroscopy 
Infra red spectrums of the prepared complexes 
were carried out using FT-IR  (Shimadzu FTIR-
8101) based on  the KBr disc method and 
compared with that of pure drug. 
 
X-ray Diffractometry 
The X-ray diffractograms were obtained using on 
X-Ray diffraction instrument (Philips Analytical-
X’Pert PRO) with Ni-filtered Cu radiation, at a 
voltage of 40kV and current of 30mA. The 
scanning speed was 2 degree/min between 2 
and 40 theta. 
 
Dissolution Rate Studies 
Dissolution studies on the pure drug, and the 
inclusion complexes prepared by different 
methods were performed in phosphate buffer 
(pH6.8) using USP six station dissolution rate 
test apparatus (VEEGO Scientific, Mumbai, 
India) with a paddle stirrer. The stirring speed 
employed was 100rpm, and the temperature was 
maintained at 37oC ± 0.5oC. Powdered samples 
of each preparation, equivalent to 40 mg of 
gliclazide, were placed in the dissolution 
medium. Samples withdrawn at different time 
intervals were determined for gliclazide content 
measuring spectrophtometrically wavelength of  





The percent yield of GPM1 and GPM2 were 
found to be in the range of 99.58% to 98.71%. 
The complexes prepared by kneading method 
(GK1 and GK2) were obtained in 98.76% to 
97.52% yield. While the percent yield of GCP1 
and GCP2 was in the range of 92.05% to 
93.24%. 
 
Phase Solubility Studies 
The phase solubility diagram of Glz-β-CD was 
obtained by plotting the changes in guest 
solubility as a function of CD concentration and 
is shown in Fig. 1. The solubility curve was 
classified as Bs type according to Higuchi and 
Connors17 indicating the limited solubility of the 
complex, since the initial rising portion was 
followed by plateau, and finally the concentration 
of GLZ decreased with the precipitation of solid 
microcrystalline complex.  
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The extent of complexation in aqueous media is 
characterized by the apparent stability constant, 
Ks. In the present study, Ks determination was 
based on the solubility diagram which required 
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Fig. 3: X-ray diffraction patterns of β-CD (A), Pure Glz (B), GPM2 (C), GK2 (D), GCP2 (E). 
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value was calculated according to the equation 
of Higuchi and Connors17 from the initial straight-
line portion of the solubility diagram. 
                      Ks = slope/ So(1-slope) 
where So is the intrinsic solubility of gliclazide in 
the absence of β-CD. The value of Ks was found 
to be 81 M-1 
 
IR Spectroscopy 
The IR spectra of the complexes together with 
the pure drug are shown in Fig. 2 for 
comparison. As can be clearly seen from the 
spectra, the characteristic bands of gliclazide at 
1352, 1438, 1709 and 1597 were modified 
significantly in the solid complexes as a result of 
complex formation.  The C-H stretching peak 
due to aromatic ring of gliclazide was absent in 
all of the complexes. The spectra of GPM1 and 
GPM2 resemble more the spectrum of pure 
gliclazide. In the case of GK1, GK2, GCP1 and 
GCP2, the characteristic bands of gliclazide at 
1352, 1438, 1709 and 1597 were modified 
significantly as a result of complex formation. 
The spectra of all the complexes made on a 
small scale were similar to the spectra of the 
corresponding samples made on a large scale. 
 
X-Ray Diffractometry 
The X-ray diffraction patterns of pure gliclazide, 
β-CD, physical mixtures, as well as kneaded and 
co-precipitated powders of the GLZ and β-CD 
are represented in Fig. 3. The peak position 
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Fig 5: Dissolution profiles of Kneaded complexes: 15min kneading at 25° ± 2.0° ( ), 30min kneading   
at 25° ± 2.0° (■), 45min kneading at 25° ± 2.0° ( ),15min kneading at 75oC(-- --),30min kneading at 
75oC  (-- --), 45min kneading at 75oC(-- --) 
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structure which peak height is the measure of 
sample crystallinity.  
The diffractograms of pure gliclazide and pure β-
CD exhibited a series of intense peaks, which 
are indicative of their crystallinity. The 
diffractogram of the physical mixture was 
constituted practically by simple superposition of 
each component, indicating the presence of 
gliclazide in crystalline state and no formation of 
a new structure. This result supports the finding 
of IR spectra. The inclusion complexes prepared 
by kneading and co-precipitation methods both 
on small and large scales showed varied 
reduction in crystallinity based on preparation 
method used.  Intensity of peak sharpness was 
greater in physical mixtures than in kneaded 
products and co-precipitates. In the 
diffractograms of GK1, GK2, GCP1 and GCP2, 
many of the peaks of gliclazide and β-CD 
disappeared while some are less intense. 
Moreover, new peaks are also seen in the 
diffractograms of GK1, GK2, GCP1 and GCP2 
indicating formation of new compound. 
 
Dissolution Studies 
The reported values were obtained by 
calculating the arithmetic mean of five 
measurements, and standard deviation bars are 
omitted to avoid overlapping. Fig. 4 shows the 
dissolution profiles of pure gliclazide, GPM1, 
GPM2, GK1, GK2, GCP1 and GCP2. While the 
pure drug is practically insoluble, all other 
powders show improvement in drug solubility. 
The extent of this enhancement in the solubility 
varies with the method of complexation and 
host-guest molar ratio. 
GPM1 and GPM2 showed the lowest 
improvement in solubility. But the solubility of 
GPM2 is more than GP1. Co-precipitation 
method gave better dissolution efficiency than 
kneading when 1:1 complexes are compared. 
But none of these dissolution curves show better 
or equal performance than the dissolution curves 
of GK2 and GCP2.  Powder prepared by 
kneaded and co-opercipitation method in 1:2 
molar ratios are produced.   
 
DISCUSSION 
The stoichiometry of the complexes in the solid 
phase evaluated  on the basis of data in the 
plateau region of the solubility diagrams and the 
component ratio was estimated as 1:2. These 
results were confirmed by chemical analysis of 
the solid complex. 
As shown by IR spectroscopy studies it was 
confirmed that all the methods are effective for 
the formation of inclusion complexes. However, 
the spectra of GPM1 and GPM2 resemble more 
to the spectrum of pure gliclazide. This means 
that the extent of complexation was less in the 
complexes made by physical mixting. While 
complexes made by kneading and co-
precipitation method showed better 
complexation, as their spectra were significantly 
different from the spectra of pure drug. 
Modification of the characteristic bands of 
gliclazide also indicates the formation of 
complex. Absence of the C-H stretching peak of 
gliclazide confirms that all the methods are 
effective for the formation of inclusion 
complexes. But GPM1 and GPM2 were more 
like the spectrum of pure gliclazide, it  means the 
extent of complexation was less in complexes 
made by physical mixture. The fact that 
complexes made by kneading and co-
precipitation methods showed greater 
complexation, is buttered by  the significantly 
different from the spectrum of pure drug.  
The inclusion complexes prepared by kneading 
and co-precipitation methods showed reduction 
in the crystallinity based on the particular 
preparation method used. Reduction in the 
intensity of peak sharpness for kneaded and co 
precipitated complexes initiate that complexation 
was practically complete.  The disappearance of 
the peaks of gliclazide and β-CD and 
appearance of new peaks indicates the 
formation of new compound. 
The lower dissolution efficiencies of GPM1 and 
GPM2 indicate that physical mixing is a less 
efficient method for complexation. In the case of 
the physical mixtures, the small rise in solubility 
when compared to, pure gliclazide is due to the 
rapid formation of inclusion complexes in the 
dissolution medium or to the wetting effect of β-
CD. Incidentally, β-CD has surfactant-like 
properties owing to the hydrophilicity of its 
exterior surface which can lower the interfacial 
tension between poorly soluble drugs and the 
dissolution medium, resulting in higher 
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dissolution rate. In the case of 1:1 molar 
complexes prepared by kneading method a 
lower amount of β-CD resulted in partial 
complexation and hence lower improvement in 
solubility while co-precipitated 1:1 powders 
exhibited considerable improvement in solubility 
proving the efficiency of this method with regard 
to inclusion complexation.   
In the case of complexes prepared in a 1:2 molar 
ratio, the similar dissolution curves suggests 
similarity in the nature of complexes prepared by 
kneading and co-precipitation. The more efficient 
method may be co-precipitation because it 
allows the formation of complex when molecules 
having appropriate energies collide in correct 
orientation, and this is helped by heat and 
stirring.  As in the case of co-precipitation 
method, inclusion complex formation takes place 
at molecular level.  Even in kneading method, 
particles are actually undergoing localized 
dissolution due to effect because of water and 
heat (is supplied by vigorous mixing). Therefore, 
if co-precipitation method forms the inclusion 
complexes from two fully soluble solutes, after 
their molecules collide in correct orientation, the 
kneading method results in inclusion complexes 
by virtue of the concurrence of several factors 
during kneading.  The presence of water 
provides the solvent for dissolving the reactants 
and precipitating the product; the high rate of 
mixing provides localized heating; sufficient time 
is required for all of the reactants to react. Thus, 
the complexes formed by kneading method also 
result in true complexes like co-precipitated ones 
if a solvent of suitable nature in appropriate 
amount is used along with appropriate period of 
trituration. Moreover, these inclusion compounds 
made by both kneading and co-precipitation 
have a low degree of crystallinity and enhances 
dissolution owing to increased drug particle 
wettability and formation of a readily soluble 
inclusion complex in the dissolution medium. 
 
Comparison of Kneading and Co-
precipitation method for scaling up 
Since the 1:2 inclusion complexes prepared by 
both kneading and co-precipitation methods 
showed similar performance in dissolution 
studies,  further studies were carried out to 
determine the easier, faster and cost effective 
method of complexation. While scaling up it was 
realized that it is far easier to deal with large 
quantities of solid than with that of liquids. Due to 
the limited solubility of CD, large volumes of 
water were used. Tank capacity, time and 
energy for heating and cooling are important 
cost factors. Treatment and disposal of the 
mother liquor obtained after collecting the 
complex is also a concern, but for kneading 
method mixers like a rapid mixer granulator can 
be used. It was found that kneading was faster 
when compared to co-precipitation. The only 
time-consuming step in kneading was drying, 
while in the case of co-precipitation, the solution 
had to be stirred for longer periods in large 
vessels with the aid of stirrers. If stirring time is 
reduced, there is reduction in the yield. 
Moreover, the time taken by large quantities of 
liquid for cooling is longer more and forced 
cooling may have effect on the crystallinity of the 
co-precipitated product. Thus less hardware 
would be required for kneading method to 
achieve scale up than for co-precipitated 
method. For reasons of simplicity, ease and 
time, further studies were carried out on 
kneading method only.  
Dissolution profiles of the complexes prepared 
by kneading for 60 minutes both at room and 
elevated temperatures are not shown in the 
figure since their release profiles were similar to 
those of to the complexes prepared in a 
kneading time of  45 minutes. Since co-
precipitation was performed at 75oC, the aim 
here was to study the role of temperature in the 
formation of inclusion complexes. . During these 
studies all other factors were constant. The only 
variable was kneading time. It is clear from the 
studies that kneading time affects the efficiency 
of inclusion complexation.  After 15min the 
complexation was incomplete.  Kneading for a 
30min period is optimum for complete 
complexation while triturating for a shorter period 
will give powders with lower dissolution profile.  




Beta cyclodextrin can be used to prepare 
suitable inclusion complexes of gliclazide. All the 
complexes prepared showed remarkable 
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increases in the water solubility of the drug.  
With increasing quantity of cyclodextrin in the 
powder, a rise in the level of complexation and 
drug solubility was obtained. Thus, kneading and 
co-precipitation methods can be used for the 
preparation of complexes but kneading method 
would be more suitable on a large scale.  
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